HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiviral treatment for Bell's palsy (idiopathic facial paralysis).

AbstractBACKGROUND:
Antiviral agents against herpes simplex virus are widely used in the treatment of idiopathic facial paralysis (Bell's palsy), but their effectiveness is uncertain. Significant morbidity can be associated with severe cases.
OBJECTIVES:
This review addresses the effect of antiviral therapy on Bell's palsy.
SEARCH STRATEGY:
We updated the search of the Cochrane Neuromuscular Disease Group Trials Register (December 2008), MEDLINE (from January 1966 to December 8 2008), EMBASE (from January 1980 to December 8 2008) and LILACS (from January 1982 to December 2008).
SELECTION CRITERIA:
Randomized trials of antivirals with and without corticosteroids versus control therapies for the treatment of Bell's palsy.
DATA COLLECTION AND ANALYSIS:
Twenty-three papers were selected for consideration.
MAIN RESULTS:
Seven trials including 1987 participants met the inclusion criteria, adding five studies to the two in the previous review.Incomplete recovery at one year. There was no significant benefit in the rate of incomplete recovery from antivirals compared with placebo (n = 1886, RR 0.88, 95% CI 0.65 to 1.18). In meta-analyses with some unexplained heterogeneity, the outcome with antivirals was significantly worse than with corticosteroids (n = 768, RR 2.82, 95% CI 1.09 to 7.32) and the outcome with antivirals plus corticosteroids was significantly better than with placebo (n = 658, RR 0.56, 95% CI 0.41 to 0.76).Motor synkinesis or crocodile tears at one year. In single trials, there was no significant difference in long term sequelae comparing antivirals and corticosteroids with corticosteroids alone (n = 99, RR 0.39, 95% CI 0.14 to 1.07) or antivirals with corticosteroids (n = 101, RR 1.03, 95% CI 0.51 to 2.07).Adverse events.There was no significant difference in rates of adverse events between antivirals and placebo (n = 1544, RR 1.06, 95% CI 0.81 to 1.38), between antivirals and corticosteroids (n = 667, RR 0.96, 95% CI 0.65 to 1.41) or between the antiviral-corticosteroid combination and placebo (n = 658, RR 1.15, 95% CI 0.79 to 1.66).
AUTHORS' CONCLUSIONS:
High quality evidence showed no significant benefit from anti-herpes simplex antivirals compared with placebo in producing complete recovery from Bell's palsy. Moderate quality evidence showed that antivirals were significantly less likely than corticosteroids to produce complete recovery.
AuthorsPauline Lockhart, Fergus Daly, Marie Pitkethly, Natalia Comerford, Frank Sullivan
JournalThe Cochrane database of systematic reviews (Cochrane Database Syst Rev) Issue 4 Pg. CD001869 (Oct 07 2009) ISSN: 1469-493X [Electronic] England
PMID19821283 (Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
Chemical References
  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Prednisolone
  • Valine
  • Valacyclovir
  • Acyclovir
Topics
  • Acyclovir (analogs & derivatives, therapeutic use)
  • Anti-Inflammatory Agents (therapeutic use)
  • Antiviral Agents (therapeutic use)
  • Bell Palsy (drug therapy, virology)
  • Drug Therapy, Combination (methods)
  • Herpes Simplex (complications, drug therapy)
  • Humans
  • Prednisolone (therapeutic use)
  • Randomized Controlled Trials as Topic
  • Valacyclovir
  • Valine (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: